Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Leaflet EDARBI 20mg tablets
- Product code:
- W58519002
- Quantity:
- 28
- Indicated for:
- hypertension
- Route of administration:
- oral
- Substance:
- azilsartan (angiotensin II receptor blocker)
- ATC
- C09CA09 — Cardiovascular system | Angiotensin II receptor blockers (arbs), plain | Angiotensin ii receptor blockers (arbs), plain
Precautions:
Hypotension / fall risk
May lower blood pressure and increase the risk of falls.
Major drug interactions
This medicine may have important interactions with other medicines.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Electrolyte disturbances
This medicine may change blood electrolyte levels.
Azilsartan is an angiotensin II receptor blocker (ARB) used in the treatment of hypertension. It works by blocking the AT1 receptors of angiotensin II, a hormone that causes vasoconstriction and sodium retention, thereby lowering blood pressure and reducing the risk of cardiovascular complications.
Azilsartan is administered orally, usually once daily, and can be used alone or in combination with other antihypertensive medications. It is indicated for adult patients with essential hypertension, providing effective and long-lasting blood pressure control.
Common side effects include dizziness, fatigue, nausea, and diarrhea. In rare cases, severe adverse reactions such as renal impairment, hyperkalemia, or allergic reactions may occur. Regular monitoring of blood pressure and renal function is essential during treatment.
Azilsartan is a modern and well-tolerated therapeutic option for managing hypertension, contributing to the reduction of major cardiovascular events.
Azilsartan is administered orally, usually once daily, and can be used alone or in combination with other antihypertensive medications. It is indicated for adult patients with essential hypertension, providing effective and long-lasting blood pressure control.
Common side effects include dizziness, fatigue, nausea, and diarrhea. In rare cases, severe adverse reactions such as renal impairment, hyperkalemia, or allergic reactions may occur. Regular monitoring of blood pressure and renal function is essential during treatment.
Azilsartan is a modern and well-tolerated therapeutic option for managing hypertension, contributing to the reduction of major cardiovascular events.
General data about EDARBI 20mg
- Substance:
- azilsartan
- Date of latest medicines list:
- 01-01-2019
- Product code:
- W58519002
- Concentration:
- 20mg
- Pharmaceutical form:
- tablets
- Quantity:
- 28
- Product type:
- Original
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for azilsartan
- 20mg
- 40mg
- 80mg